International drive to illuminate delirium: A developing public health blueprint for action

Presently, there is a clear societal and demographic imperative to and deliver interventions that are effective in reducing. With the high failure rate of compounds in clinical trials, and pharmaceutical development cycles typically lasting decades, hybrid person-with-dementia-centered approach that precisely inte- pharmaceutical, non-pharmaceutical, lifestyle modification, and care for the individual may offer more immediate results for dementia burden. One important, tangible, and overlooked with this proposed approach may be through the recognition prevention of delirium.